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Oxygen exposure in premature infants is a major risk
factor for bronchopulmonary dysplasia and can im-
pair the host response to respiratory viral infections
later in life. Similarly, adult mice exposed to hyper-
oxia as neonates display alveolar simplification asso-
ciated with a reduced number of alveolar epithelial
type II cells and exhibit persistent inflammation, fi-
brosis, and mortality when infected with influenza A
virus. Because type II cells participate in innate im-
munity and alveolar repair, their loss may contribute
to oxygen-mediated sensitivity to viral infection. A
genomewide screening of type II cells identified eosi-
nophil-associated RNase 1 (Ear1). Ear1 was also de-
tected in airway epithelium and was reduced in lungs
of mice exposed to neonatal hyperoxia. Electropora-
tion-mediated gene delivery of Ear1 to the lung before
infection successfully reduced viral replication and leu-
kocyte recruitment during infection. It also diminished
the enhancedmorbidity andmortality attributed to neo-
natal hyperoxia. These findings demonstrate that novel
epithelial expression of Ear1 functions to limit influ-
enza A virus infection, and its loss contributes to oxy-
gen-associated epithelial injury and fibrosis after infec-
tion. People born prematurely may have defects in
epithelial innate immunity that increase their risk for
respiratory viral infections. (Am J Pathol 2012, 181:
441–451; http://dx.doi.org/10.1016/j.ajpath.2012.05.005)
Premature exposure to oxygen is a major risk factor for
neonatal lung disease and can promote bronchopulmo-nary dysplasia (BPD), a chronic form of disease fre-
quently seen in preterm infants with very low birth
weight.1 Lungs of infants who died of BPD are less vas-
cularized and have fewer and larger alveoli.2 Although
the use of exogenous surfactant, antenatal steroids, and
milder ventilation strategies has markedly increased sur-
vival of preterm infants, survivors continue to show de-
creased lung capacity at 5 to 10 years of age and even
as young adults.3–5 Moreover, these children are often
hospitalized again after respiratory viral infection and are at
increased risk for asthma and other cardiopulmonary-re-
lated diseases, including hypertension.6–8 Despite a clear
appreciation that premature exposure to oxygen contrib-
utes to BPD, how early-life oxygen therapy permanently
disrupts lung development and modifies the ability to re-
spond to respiratory infections later in life is not known.
Studies in a variety of animal models reveal that neonatal
exposure to supplemental oxygen (hyperoxia) affects lung
development in several ways, yet the contribution of these
effects to long-term health and disease is not fully under-
stood.9 Infants who have died of BPD have pronounced
disruptions in vascular development, but it remains uncer-
tain whether alterations in vascular development are the
sole cause of morbidity in those who survive. Indeed, long-
term changes in alveolar simplification and airway respon-
siveness observed in animal studies suggest that the oxy-
gen-injured lung may never fully recover.10–12 These
studies also suggest that changes in vascular development
are not the only modification that affects survival, lung func-
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gen exposure in mice reveal changes in the balance of
alveolar epithelial cell types. Along with patent alveolar sim-
plification, lungs of adult mice that were exposed to 100%
oxygen during postnatal days 1 to 4 have fewer alveolar
epithelial type II cells, as defined by reduced number of
cells expressing prosurfactant protein B (proSP-B), prosur-
factant protein C (proSP-C), or enhanced green fluores-
cence protein (EGFP) driven by the human surfactant pro-
tein C promoter.11 Lungs of these mice also express more
T1 and AQP5, genes expressed by type I epithelial cells.
Because type II cells are progenitor cells for type I cells,
even short-term neonatal hyperoxia may have depleted or
reprogrammed type II cells such that the overall balance is
altered, with the simplified lung havingmore type I cells. The
consequences of such an imbalance are not completely
understood, but it possibly contributes to the poorer re-
sponses to respiratory infection reported in children born
prematurely.
We have previously reported that adult mice exposed
to hyperoxia as neonates display persistent and en-
hanced recruitment of leukocytes, pulmonary fibrosis,
and mortality when infected with a sublethal dose of
influenza A virus.14 Neonatal hyperoxia could alter host
responses to influenza virus infection by compromising
any of the innate and adaptive host defense pathways
involved in controlling infection. Given that alveolar type II
cells secrete proteins involved in innate immunity and
surfactant homeostasis and participate in alveolar epithe-
lial repair, their reduction in adult mice exposed to hyper-
oxia as neonates may adversely affect the host response
to respiratory viral infections.15–19 We report a study of
how the loss of type II cells in adult mice exposed to neo-
natal hyperoxia led us to identify a novel mechanism of
innate host defense in airway and alveolar epithelial cells
that is disrupted by neonatal hyperoxia. Understanding how
short-term hyperoxia permanently disrupts lung develop-
ment and the host response to respiratory viral infections is
important because it may provide insight into why children
born prematurely also display permanent changes in lung
function and host defense later in life.
Materials and Methods
Exposure of Mice to Hyperoxia as Neonates
and Influenza A Virus as Adults
Newborn C57Bl/6J mice were exposed to room air or
100% oxygen (hyperoxia) between postnatal days 1 and
4 and then returned to room air.14 At 8 weeks of age,
female mice were infected by intranasal administration of
120 hemagglutinating units of influenza A virus, strain
HKx31 (H3N2). Female mice were used for the study be-
cause they consistently exhibit a more robust response to
neonatal hyperoxia and infection with influenza A virus than
males. Mechanisms by which sex affects the immune re-
sponse to pathogens is complex and not fully understood.20
Mice were housed in microisolator cages in a specified
pathogen-free facility, and the University Committee on An-
imal Resources approved all protocols using mice.RNA Isolation and Hybridization to Affymetrix
Probes
The generation, characterization, and isolation of type II
cells from transgenic human surfactant protein-C (hSP-
C)/EGFP mice in the C57Bl/6J inbred background have
been described previously.21 Total RNA was isolated
from EGFP-positive and EGFP-negative type II cells har-
vested from uninfected 8- to 10-week-old mice using
RNeasy (Qiagen, Valencia, CA). RNA integrity was vali-
dated by the presence of strong ribosomal RNA bands
with an Agilent Bioanalyzer (Agilent Technologies, Santa
Clara, CA). The RNA was amplified during reverse tran-
scription to cDNA and biotinylated with Ovation kits from
NuGEN (San Carlos, CA). Biotinylated cDNA was hybrid-
ized overnight to the mouse genome 430 2.0 array from
Affymetrix. Arrays were stained with streptavidin-phyco-
erythrin as recommended by Affymetrix. The arrays were
scanned for phycoerythrin fluorescence, and the spot
intensities were normalized across arrays with the Ge-
neChip Robust Multiarray Averaging method. Quantita-
tive real-time PCR was performed with cDNA that was
amplified during reverse transcription with WT-Ovation
kits (NuGEN). Taqman primer and probe sets were pur-
chased from Applied Biosystems (Carlsbad, CA), which
designed these proprietary assays for use with standard
thermal cycling conditions and detector settings that are
the same for all assays. These assays were performed
with the Applied Biosystems 7900HT real-time PCR in-
strument and were analyzed with Applied Biosystems
SDS software version 2.4, using -actin as the reference
transcript. Real-time PCR of EAR cDNA was performed
by amplifying bases 14 to 107 (see Supplemental Figure
S1 at http://ajp.amjpathol.org) and detecting the amplicon
with locked nucleic acid probe 18 from the Roche Uni-
versal Probe Library (Roche Applied Science, Indianap-
olis, IN).
Electroporation-Mediated Plasmid Delivery
Plasmids were purified using Qiagen Giga-prep kits and
resuspended at 1 mg/mL in 10 mmol/L Tris, pH 8.0, 1
mmol/L EDTA, and 140 mmol/L NaCl. Adult mice (8 to 10
weeks old) were lightly anesthetized with isoflurane and
placed in the supine position. Pediatric cutaneous pace-
maker electrodes (Quik-Combo RTS; Medtronic Physio-
Control Corporation, Redmond, WA) cut to 1 2 cm were
placed on either side of the chest under the forelimbs,
using a small amount of petroleum jelly to aid conduc-
tance.22 Next, 50 L of plasmid was administered to the
lungs by tracheal instillation during inspiration, and a series
of eight consecutive square-wave electric pulses (200 V/cm
for 10 milliseconds each) were immediately administered
using an ECM830 electroporator (Gentronics, West Holly-
wood, CA). Mice were monitored as they recovered from
the anesthesia and then returned to the vivarium.
RT-PCR
Total RNA was isolated from frozen lung homogenates or
isolated type II cells with Trizol (Invitrogen, Grand Island,
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cDNA Synthesis kit (Bio-Rad, Hercules, CA) using random
hexamer primers. For identifying Ear genes expressed in
lung and type II cells, Ear primers (forward primer: 5=-
GATCGAATTCATGGGTCCGAAGCTGCTTGAGT-3= and
reverse primer: 5=-GATCGGATCCCTAAAATGTCCCATC-
CAAGTGA-3=) were used to amplify products that were
cloned into pBluescript vector (Stratagene, Santa Clara,
CA) and sequenced. For semiquantitative RT-PCR, Ear (for-
ward primer: 5=-GATCGAATTCAATACTTTTCTTCATACAA-3=
and reverse primer: 5=-GATCGGATCCGTGAACTGGAAC-
CACTGGATA-3=) and -actin (forward 5=-GTATGGAATC-
CTGTGGCATCC-3= and reverse 5=-TACGCAGCTCAG-
TAACAGTCC-3=) primers were used to amplify aliquots of
cDNA (2 and 1 L, respectively) by PCR. The thermal
cycling profile for Ear and -actin was 94°C for 4 minutes,
followed by 35 (Ear) or 26 (-actin) cycles of 94°C for 30
seconds, 58°C for 30 seconds, and 72°C for 1 minute,
with a final extension of 72°C for 5 minutes. The number
of cycles was based on prior studies confirming that
amplification was in the linear range.
Immunohistochemistry
Lungs were inflation fixed with 10% neutral-buffered for-
malin, embedded in paraffin, and sectioned as previously
described.11,23 Sections were incubated with rabbit anti-
proSP-C,11 rabbit anti-Ear (1:500, James and Nancy Lee,
Mayo Clinic, Scottsdale, AZ24), or mouse anti–-smooth
muscle actin14 antibody overnight at 4°C. Slides were
washed three times in PBS with 0.05% Triton-X before in-
cubating for 1 hour with appropriate fluorescently labeled
secondary antibodies (Jackson Immunoresearch, West
Grove, PA). Gomori’s trichrome stain was performed ac-
cording to the manufacturer’s instructions (Richard-Allan
Scientific, Kalamazoo, MI). All slides were immersed in
DAPI and visualized with a Nikon E-800 fluorescence mi-
croscope (Nikon Instruments, Melville, NY). Images were
captured with a SPOT-RT digital camera (Diagnostic
Instruments, Sterling Heights, MI). For quantifying pos-
itively stained cells, five random images of the right
lung lobes were captured at 20 magnification.11,23 A
minimum of 200 cells per image were counted using
Metamorph analysis software version 7.7 (Molecular
Devices, LLC, Sunnyvale, CA).
In Situ Hybridization
The Ear1 open reading frame was generated by PCR of
pVL-mEar1 using the forward 5=-ATGGGTCCGAAGCT-
GCTTGAGTCT-3= primer and reverse 5=-CTAAAATGTC-
CCATCCAAGTGAAC-3= primer. An EcoRI site was
added to the 5= primer, and a BamHI site was added to
the 3= primer. The EcoRI- and BamHI-digested fragment
was ligated into pBluescript II KS plasmid, generating
pBS-Ear1. pBS-Ear1 was linearized and antisense and
sense probes were synthesized using T7 and T3 promot-
ers in the presence of digoxigenin (DIG)-11-UTP (Roche
Diagnostics Corporation, Indianapolis, IA). DIG-labeled
probes were hydrolyzed to a length of approximately 200
bp by alkaline hydrolysis and quantified by using analkaline phosphate–conjugated anti-DIG antibody in a
dot blot. Paraffin-embedded sections of lungs fixed in
10% neutral buffered formalin were deparaffinized in xy-
lene and dehydrated followed by proteinase K digestion.
Slides were fixed in 4% formaldehyde, equilibrated with
100 mmol/L triethanolamine HCl (pH 8.0), and treated
with 0.25% acetic anhydride. The slides were then
washed in 2 saline sodium citrate (SSC), and hybrid-
ization was performed for 16 hours at 49°C using a hy-
bridization solution containing 50 pg/L of DIG-labeled
probe. The hybridization solution consisted of 45% form-
amide, 4 SSC, 10 mmol/L DTT 1 Denhardt’s reagent,
10% dextran sulfate, and 1 mg/mL of yeast tRNA. Sec-
tions were washed, denatured with 1% hydrogen perox-
ide, digested with RNase A, and washed in RNase buffer.
The slides were then washed in 0.1 SSC at 58°C and
0.1 SSC at room temperature, blocked with 3% normal
sheep serum, and incubated in horseradish peroxidase–
conjugated anti-DIG antibody. Tyramide amplification
(NEN Life Science Products, Boston, MA) was performed
and slides were incubated in Vectastain ABC (Vector Lab-
oratories, Burlingame, CA) before detection with 3,3=-di-
aminobenzidine. Tissues were counterstained with hema-
toxylin, and images were visualized with a Nikon E800
fluorescencemicroscope (Nikon Instruments) and captured
with a SPOT-RT digital camera (Diagnostic Instruments).
Viral Foci Assay
Frozen lungs from individual mice were resuspended in 1
mL of ice-cold PBS, containing 100 U/mL of penicillin and
0.1 mg/mL of streptomycin, and mechanically homoge-
nized (Tissuemiser; Fisher Scientific, Waltham, MA). After
centrifugation of tissue homogenates (400  g for 5 min-
utes at 4°C), 15 L of the supernatant was serially diluted
(1:100 to 1:107) in zero-serum refeed medium containing
penicillin (100 U/mL), streptomycin (100 g/mL), genta-
micin (50 g/mL), amphotericin B (1.25 g/mL) (PSGA)
containing 4 g/mL of trypsin. Virus titers were deter-
mined by immunocytochemistry on confluent Madin-
Darby canine kidney cells in 96-well flat bottom tissue
culture plates in duplicate.25 Briefly, cells were incubated
with 100 L of serially diluted supernatant and centri-
fuged for 1.5 hours at 700  g, after which wells were
aspirated and replaced with fresh zero-serum refeed me-
dia. After overnight incubation at 33°C, cells were fixed
with 80% acetone/20% water for 30 minutes at 20°C,
rinsed with staining wash buffer (1 PBS, 2% fetal bovine
serum, 0.1% sodium azide), and then incubated with a
biotinylated anti-influenza A monoclonal antibody (1:900
dilution in staining wash buffer; Millipore, Billerica, MA)
for 1 hour at 38°C. Cells were then incubated with strepta-
vidin-labeled alkaline phosphatase (1:500 dilution in PBS;
Sigma-Aldrich, St Louis, MO) for 1 hour at room temper-
ature, and viral foci, indicative of influenza infection in the
cell monolayer, were detected on addition of 5-bromo-4-
chloro-3=-indolyphosphate p-toluidine salt and nitro-blue
tetrazolium chloride (Sigma-Aldrich). Viral foci were
counted and viral foci units per milliliter were determined.
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Counting of Cells
Leukocytes were collected by bronchoalveolar lavage
(BAL). The trachea was catheterized and the lungs were
lavaged with three separate 1-mL aliquots of ice-cold
PBS containing 1% bovine serum albumin and 10%
HEPES. BAL fluid and cells were separated by centrifu-
gation (200  g). Supernatant from the first lavage was
retained as BAL fluid and was stored at 80°C for quan-
tifying levels of monocyte chemotactic protein 1 (MCP-1)
by enzyme-linked immunosorbent assay (R&D Systems,
Minneapolis, MN). Cells recovered from all three lavages
were pooled and erythrocytes were removed by treat-
ment with ammonium chloride lysing solution (0.15 M
NH4Cl, 10 mmol/L NaHCO3, and 1 mmol/L EDTA). The
total number of cells was enumerated using a TC10 au-
tomated cell counter (Bio-Rad). Cells from individual
mice were transferred to microscope slides using a cy-
tologic centrifuge and were stained with Diff-Quik. Mono-
cytes or macrophages, neutrophils, and lymphocytes
were enumerated by differential cell counts of at least 200
cells on coded slides by two independent investigators.
Western Blot Analysis
Cells and whole lungs were harvested in lysis buffer, and
protein concentrations were determined as previously
published.11 Samples were diluted in Laemmli buffer and
separated by SDS-PAGE and transferred to polyvi-
nylidene difluoride membranes (Pall Life Sciences, Port
Washington, NY). The membranes were then incubated
with anti-Ear (1:500), anti-ABCA3 (1:500; Seven Hills, Cin-
ciannati, OH), E-cadherin (1:500; Cell Signaling Technol-
ogy, Danvers, MA), or anti–Clara cell secretory protein
(CCSP)11 antibodies with -actin (1:2500; Sigma Chem-
ical Company, St. Louis, MO) as a loading control. Mem-
branes were then incubated in horseradish peroxidase–
conjugated secondary antibodies (anti-mouse at 1:4000
or anti-rabbit at 1:5000; Southern Biotechnology) and
visualized by chemiluminescence (Amersham Biosci-
ences, Sunnyvale, CA). Quantification of Western blots
was performed using ImageJ software version 1.46 (NIH,
Bethesda, MD).
Statistical Analysis
Statistical analyses of values were assessed by unpaired
Student’s t-test for single comparisons or an analysis of
variance using Fisher’s procedure post hoc analysis for
group comparisons using Statview software (Abacus
Concepts, Piscataway, NJ). Mortality was evaluated with
Kaplan-Meier and analyzed for significance with Mantel-
Cox test using StatView software version 5.0. Values are
expressed as mean  SEM with P  0.05 considered
significant.Results
Ear1 Can Be Detected in Some Epithelial
Type II Cells
Previous work revealed adult mice exposed to neonatal
hyperoxia have fewer type II cells based on counting
cells expressing proSP-C or EGFP controlled by the hu-
man SP-C promoter.11 This finding led us to hypothesize
that neonatal hyperoxia reduced expression of prosurfac-
tant protein A (SP-A) and prosurfactant protein D (SP-D),
proteins expressed by type II cells that protect against
respiratory viruses. However, levels of SP-A or SP-D in
BAL fluid were similar in mice exposed to room air or
hyperoxia (data not shown). We therefore decided to use
Affymetrix arrays to search for novel innate immune
genes expressed by type II cells. Unfortunately, pure
populations of mouse type II cells are difficult to obtain.
However, we have previously shown how the intrinsic
green fluorescence of EGFP can be used to isolate highly
pure populations of type II cells from hSP-C/EGFP trans-
genic mice using fluorescence-activated cell sorting.21
Because EGFP is detected in approximately 5% of type II
cells, we first isolated type II cells using Dispase and then
separated the cells into EGFP-positive and EGFP-nega-
tive populations based on their intrinsic green fluores-
cence (see Supplemental Figure S2 at http://ajp.
amjpathol.org). RNA was isolated, converted to cDNA,
and hybridized to the mouse genome 430 2.0 array from
Affymetrix. A hierarchal cluster analysis of the 25 most
abundantly expressed genes revealed that EGFP-posi-
tive and EGFP-negative cells expressed SP-C, as well as
SP-A, SP-B, SP-D, lysozyme, forkhead box protein 1A,
and thyroid transcription factor 1 (see Supplemental Fig-
ure S2 at http://ajp.amjpathol.org). We then looked at the
25 most abundantly expressed genes whose expression
was fivefold or greater in EGFP-positive or EGFP-nega-
tive type II cells. Changes less than fivefold were not
always consistent and were therefore ignored. Approxi-
mately 250 (0.6%) of the 45,000 probes on the array
were selectively detected in EGFP-positive cells,
whereas approximately 15,000 (3.3%) were selectively
detected in the EGFP-negative cells. Intriguingly, EGFP-
positive cells selectively expressed genes previously
identified as playing a role in activating bone morphoge-
netic protein signaling, asymmetric cell division (Par-3,
cdc42-binding protein, Magi1, dock-1, and dock-9), and
protection against RNA viruses (eosinophil-associated
RNase 2 and 3, also called Ear2 and Ear3) (see Supple-
mental Table S1 at http://ajp.amjpathol.org). On the other
hand, EGFP-negative type II cells expressed claudin 4,
matrix metallopeptidase 3, hemoglobin, and many other
genes, some of which might be expressed by non–type II
cells that co-purified during the initial isolation. Expres-
sion of some of these genes was validated by quantitative
RT-PCR (see Supplemental Table S2 at http://ajp.
amjpathol.org). The complete array data were deposited
in the Gene Expression Omnibus at the National Center
for Biological Information on December 2, 2010, and may
be accessed under accession number GSE25778 (http://
www.ncbi.nlm.nih.gov/geo).
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tive type II cells was of interest because Ear proteins
possess potent bactericidal, helminthotoxic, and antiviral
properties when expressed in cell lines (for review see
Rosenberg26). However, expression of Ear proteins in the
respiratory epithelium has not been reported, and func-
tion of Ear proteins during in vivo infection with influenza A
viruses has not been well characterized. Mus musculus
expresses 14 highly homologous members of this family
that can only be distinguished by sequence analysis.27,28
Realizing that the array probes were unlikely to distin-
guish the individual isoforms, Ear cDNAs were amplified
from RNA isolated from whole lung of nontransgenic mice
or EGFP-positive type II cells isolated from transgenic
mice and sequenced (see Supplemental Figure S1 at
http://ajp.amjpathol.org). Ear1 and Ear2 were the only iso-
forms detected in whole lung (four Ear1 and eight Ear2
clones) and EGFP-positive type II cells (10 Ear1, one
Ear2, and three mutant Ear1 clones). When the study was
repeated, slightly more Ear2 clones were obtained in the
EGFP-positive type II cells. To validate that type II cells
express Ear genes, lung sections from nontransgenic
adult mice were immunostained with an antibody that
recognizes all known Ear proteins. Ear-positive staining
was restricted to alveolar cells and occasionally over-
lapped with proSP-C (Figure 1). This finding confirms an
earlier report that found that Ear1 and Ear2 are the only
forms detected in healthy adult mouse lung and extends
it by showing expression by some type II cells.28
Neonatal Hyperoxia Suppresses Epithelial
Expression of Ear1 in Nontransgenic Mice
Because adult mice exposed to hyperoxia as neonates
ProSP-C Ear 
DAPI Merged 
Figure 1. Ear can be detected in some type II cells by immunostaining.
Lungs from uninfected adult mice were immunostained for proSP-C (red) and
Ear (green) and counterstained with DAPI (blue). EAR-positive staining is
clearly evident in the cytoplasm of some but not all proSP-C–positive cells.have fewer type II cells and some type II cells expressEar1 mRNA, we hypothesized that neonatal hyperoxia
reduces expression of Ear1. Ear protein was readily de-
tected in lung homogenates of nontransgenic C57Bl/6J
adult mice and was reduced in siblings that had been
exposed to hyperoxia as neonates (Figure 2A). Ear
mRNA was also reduced in some but not all adult mice
exposed to hyperoxia as neonates (Figure 3B). Further,
Ear mRNA was detected by in situ hybridization in airway
epithelium and some alveolar cells of adult mice exposed
to room air (Figure 3C). It was reduced in the airway
epithelium and not easily detected in alveoli of sibling
mice exposed to hyperoxia as neonates. Hence, adult
mice exposed to neonatal hyperoxia express lesser Ear
than siblings exposed to room air.
Electroporation-Mediated Gene Delivery of Ear1
Protects Against Influenza A Virus Infection
Given that Ear proteins can inhibit replication of respira-
tory syncytial virus, hepatitis B virus, and HIV virus,29–33
reduced expression of Ear1 in adult mice exposed to
hyperoxia could allow for greater influenza virus expan-
sion during infection. However, viral titers were usually
not different between the two groups of mice on any
given day, and virus was still efficiently cleared by postin-
fection day 9 (see Supplemental Figure S3 at http://ajp.
amjpathol.org). On the other hand, when analyzed across
the entire course of infection, viral titers were modestly
but significantly higher in infected mice exposed to hy-
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Figure 2. Neonatal hyperoxia suppresses Ear expression in adult mice. A:
Ear protein was detected in lung homogenates of mice exposed to room air
(RA) or hyperoxia (O2) as neonates. Expression of Ear in mice exposed to
room air (white bars) or hyperoxia (gray bars) was graphed relative to -actin
(n  3 to 6 mice per group; *P  0.05). B: Ear mRNA was detected by
semiquantitative RT-PCR. Expression of Ear mRNA in mice exposed to RA or
O2 were graphed relative to -actin (n  3 to 6 mice per group; *P  0.04).
C: Lung tissues from mice exposed to room air or hyperoxia at birth were
hybridized with antisense or sense Ear1 riboprobe and counterstained with
hematoxylin. Thick arrows indicate positive airway staining, and thin
arrows depict positive alveolar staining. Scale bar  100 m (B). Mean
values from a single experiment reproduced three to five times with similar
results.
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AJP August 2012, Vol. 181, No. 2peroxia (P  0.03 by analysis of variance). To determine
whether this could be attributed to lower levels of Ear1,
we overexpressed Ear1 using electroporation-mediated
delivery of expression plasmids. This method has been
used to efficiently drive gene expression to a nonproliferat-
ing organ, such as the lung, without inducing an inflamma-
tory response.34 To assess whether restoring Ear1 expres-
sion would protect against influenza virus infection, porcine
cytomegalovirus (pCMV)–control (empty vector) or pCMV-
Ear1 plasmids were first instilled intratracheally into the
lungs of naive adult mice exposed to room air or hyperoxia
as neonates. The mice were electroporated to facilitate up-
take of the plasmid and recovered for 48 hours to allow
expression of Ear1. Electroporation-mediated delivery of
pCMV-Ear1 plasmid increased expression of Ear1 ap-
proximately twofold in both groups of mice (Figure 3A).
Even though electroporation with this plasmid facilitates
expression in airway epithelium, Ear1 immunostaining
was only observed in alveolar cells (Figure 3B).
We next determined whether Ear1 gene delivery pro-
tects against influenza A virus infection. The pCMV-con-
trol or pCMV-Ear1 plasmids were electroporated into the
lungs of mice exposed to room air at birth and then
A
B
RA 
O2 
Control      Ear 
Fo
ld
 c
ha
ng
e 
0 
0.4 
0.8 
1.2 
1.6 *** **
* 
Ear1           Control Control          Ear1
   RA      O2 
Ear 
-Actin 
Figure 3. Electroporation-mediated gene delivery effectively drives high-
level expression of Ear1 in the lung. Lungs of adult mice exposed to room air
(RA) or hyperoxia (O2) as neonates were electroporated with empty vector
(control) or plasmid-expressing Ear1 (Ear1). A: Lungs were immunostained
for Ear (red) and counterstained with DAPI (blue). Scale bar  100 mol/L.
B: Ear protein was detected by immunoblotting lung homogenates, and
levels of expression were graphed as fold change relative to -actin (n  3
mice per group; *P  0.002 and **P  0.05 compared with RA control and
***P  0.001 compared with O2 control).infected 48 hours later with a sublethal dose of influenzaA virus. Consistent with its antiviral properties, overex-
pression of Ear1 significantly reduced viral titers and the
number of leukocytes recruited to the lung on postinfec-
tion day 5 (Figures 4, A and B). Differential counts of
macrophages, neutrophils, and lymphocytes were not
different, implying overexpression of Ear1 had reduced
the recruitment of those leukocytes examined and not just
one cell type (data not shown). Overexpression of Ear1
also modestly, but not significantly, attenuated weight
loss through postinfection day 5 (Figure 4C). Leukocyte
recruitment, alveolar swelling, and airway injury seen in
infected mice was also less pronounced in infected mice
administered Ear1 before infection (Figure 4D).
We then investigated in more detail whether restoring
Ear1 expression in mice exposed to hyperoxia as neo-
nates would mitigate the morbidity and mortality seen
when infected with the same sublethal dose of influenza
A virus. Gene delivery of Ear1 significantly reduced viral
titers on postinfection days 3 and 5 but not on day 7, and
this was associated with reduced number of leukocytes
recruited to the lung on day 5 (Figures 5, A and B). As
seen with the infected mice born into room air, overex-
pression of Ear1 reduced recruitment of macrophages,
neutrophils, and lymphocytes to the airways (data not
shown). Overexpression of Ear1 also significantly re-
duced levels of MCP-1, a chemokine whose expression
during infection is augmented by prior exposure to oxy-
gen,14 from 284.1  29.7 pg/mL to 165.2  12.6 pg/mL
(P  0.005, n  9 control plasmids and n  7 Ear1
plasmids). Interestingly, overexpression of Ear1 resulted
in a more robust reduction in the levels of MCP-1 in
infected siblings exposed to room air, from 203.6  38.2
pg/mL to 12.2  5.5 pg/mL (P  0.002, n  6 control
plasmids and n  5 Ear1 plasmids). Overexpression of
Ear 1 in infected mice exposed to hyperoxia also signif-
icantly attenuated the pronounced weight loss observed
on postinfection days 6 and 7 and as a group (P 0.001)
through postinfection day 14 (Figure 5C). Perhaps most
striking, none of the mice expressing Ear1 died, whereas
50% of the mice receiving control plasmid died by postin-
fection day 14 (Figure 5D). The study was repeated two
more times, and in both cases, none of the mice receiving
pCMV-Ear1 plasmid died (n  17 mice), whereas 50% of
mice receiving the control plasmid died (n  19 mice).
Moreover, none of the oxygen-treated mice died during
infection when electroporated with plasmid expressing
the related isoform Ear2 (n  9, data not shown).
Persistent inflammation and fibrotic scarring were
readily evident in the surviving mice that were adminis-
tered control plasmid (Figure 6A). Fibrotic regions
stained positively for -smooth muscle actin, indicative of
activated myofibroblasts, and thickened collagen bun-
dles were observed using trichrome staining (Figures 6,
C and E). This severe condition was rarely seen in in-
fected siblings administered plasmid expressing Ear1
(Figures 6, B, D, and F). Although some interstitial thick-
ening was observed, it stained weakly for -smooth mus-
cle actin or trichrome. In fact, with the exception of
alveolar simplification attributed to neonatal oxygen ex-
posure, fairly normal alveolar architecture was evident
throughout most of the lung and was routinely observed
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AJP August 2012, Vol. 181, No. 2in all of the mice on postinfection day 14. By sampling
lungs on postinfection days 3, 5, 9, and 14 (see Supple-
mental Figure S4 at http://ajp.amjpathol.org), it was clear
that Ear1 markedly reduced infection-associated symp-
toms throughout the infection.
Given that severe epithelial injury in general, and es-
pecially to type II cells, often occurs in pulmonary fibro-
sis,35,36 we investigated whether neonatal oxygen sensi-
tized the respiratory epithelium to virus-induced epithelial
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Figure 5. Electroporation-mediated gene delivery of Ear1 protects oxygen-
exposed mice against influenza A virus infection. Lungs of adult mice ex-
posed to hyperoxia (O2) as neonates were electroporated with empty vector
(control) or plasmid-expressing Ear1 (Ear1). Mice were infected intranasally
with influenza A virus 48 hours later. A: Overexpression of Ear1 significantly
reduced viral titers on postinfection days 3 and 5 (*P  0.005). Each dot
represents the virus titer in an individual mouse. B: Overexpression of Ear1
significantly reduced the number of inflammatory cells recruited into the lung
on postinfection day 5 (n 9 mice per group; **P 0.05). C:Overexpression
of Ear1 significantly reduced weight loss of infected adult mice exposed to
hyperoxia as neonates (n  10 control plasmids and 8 Ear1 plasmids; *P 
0.0001). D: Overexpression of Ear1 enhanced survival of infected young
adult mice exposed to hyperoxia as neonates (n  10 control plasmids and
8 Ear1 plasmids; P  0.05). Mean values from a single experiment repro-
duced three to five times with similar results.injury. However, it was difficult to use proSP-C as a
marker of type II cells during infection because levels of
proSP-C are low in adult mice exposed to neonatal hy-
peroxia.11 Expression of ABCA3 (ATP-binding cassette
transporter of the A subfamily), a protein highly ex-
pressed in type II cells and involved in trafficking of
surfactant phospholipids to lamellar bodies, was there-
fore used as a biomarker of type II cells. In the absence
of infection, the 150-kDa mature ABCA3 protein was
readily detected in lung homogenates of all mice exam-
ined (Figure 7A). Although ABCA3 was present in the
lungs of room air-exposed mice on postinfection day 5, it
was not detected in infected siblings that had been ex-
posed to hyperoxia as neonates (Figure 7B). Interest-
ingly, the loss of ABCA3 was not seen in infected mice
exposed to hyperoxia if they were administered Ear1
expression plasmid before infection. We also evaluated
expression of CCSP as an indicator of how Ear affected
the airway epithelium and expression of E-cadherin as an
indicator of how Ear affected the entire respiratory epi-
thelium. Before infection, levels of CCSP and E-cadherin
were comparable among the three groups of mice (Fig-
ure 7A). In contrast, infected mice exposed to hyperoxia
as neonates expressed less CCSP and E-cadherin than
infected siblings that had been exposed to room air;
however, this reduction was not observed when Ear1
plasmid was administered (Figure 7B). Collectively, these
findings suggest that neonatal oxygen sensitizes the re-
spiratory epithelium to influenza A virus infection and
expression of Ear1 attenuates this increased sensitivity.
Discussion
Influenza A viruses are a common cause of illness in the
general population, and children born prematurely are at
increased risk of complications due to infection with influ-
Ear1
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Figure 4. Electroporation-mediated gene deliv-
ery of Ear1 protects room air–exposed mice
against influenza A virus infection. Lungs of
adult mice exposed to room air as neonates
were electroporated with empty vector (control)
or plasmid-expressing Ear1 (Ear1). Mice were
infected intranasally with influenza A virus 48
hours later. A: Overexpression of Ear1 signifi-
cantly reduced viral titers on postinfection day 5
(*P  0.005). Each dot represents the virus titer
in an individual mouse. B: Overexpression of
Ear1 significantly reduced the number of inflam-
matory cells recruited into the lung on postin-
fection day 5 (n  6 control plasmids and 7 Ear1
plasmids; **P  0.02). C: Expression of Ear 1 did
not significantly diminish weight loss during in-
fection (n 13 mice per group, P 0.21). Mean
values from a single experiment reproduced two
to three times with similar results. D: H& E stain-
ing of lungs on postinfection day 5 showing
overexpression of Ear1 reduced leukocyte re-
cruitment, alveolar edema, and airway injury.
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AJP August 2012, Vol. 181, No. 2cytial virus (RSV). These viruses primarily infect cells of the
respiratory tract due to the selective binding of viral coat
proteins to specific terminal oligosaccharides on sialic acid
residues, which are typically found on airway epithelial cells,
alveolar epithelial type II cells, and antigen-presenting
Control      Ear1   
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Figure 6. Electroporation-mediated gene delivery of Ear1 attenuates fibrotic
repair of lungs from infected mice exposed to hyperoxia as neonates. Lungs
of adult mice exposed to hyperoxia (O2) as neonates were electroporated
with empty vector control (A, C, and E) or plasmid-expressing Ear1 (B, D,
and F). Mice were infected intranasally with influenza A virus 2 days later.
Lungs were fixed on postinfection day 14 and stained with H&E (A and B),
-smooth muscle actin (red) with DAPI nuclear counterstain (C and D), or
Gomori’s trichrome (E and F). Boxes in E and F are magnified below each
respective image. Scale bar  100 m (A–F).
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hyperoxia increases sensitivity of young adult mice to influ-
enza A virus infection. Increased sensitivity was not attrib-
uted to redistribution of sialic acid receptors required for
infection because staining with lectin fromMaackia amuren-
sis was not qualitatively different between the two groups of
mice (data not shown). Instead, increased sensitivity was
attributed in part to less epithelial expression of Ear,
particularly Ear1, which is a host defense protein se-
creted by eosinophils, macrophages, and neutro-
phils.24,38,39 Reduced expression of Ear1 is unlikely to be
the only reason why neonatal oxygen increases sensitiv-
ity to viral infection because overexpression of Ear1 was
more effective at attenuating the host response in room
air–exposed mice than in hyperoxia-exposed siblings.
Although modulation of Ear proteins may be only one of
several targeted pathways, the suppression of innate de-
fense proteins, such as Ear1, in adult mice exposed to
neonatal hyperoxia is an exciting discovery that may help
explain why children born prematurely respond poorly to
respiratory viruses.
Ear1 is a member of the RNase A superfamily consist-
ing of 13 members in human and 14 in Mus musculus (for
review see Rosenberg26 and Cho et al40). All members of
this family are located on one contiguous region of chro-
mosomes 10 and 14 and are rapidly evolving through
gene duplication and accumulation of missense muta-
tions.27,40 In humans, Ears 1 through 8 retain amino acids
in their catalytic subunits required for RNase activity,
whereas Ears 9 through 13 have additional differences in
their amino-terminus and appear to play a role in male
reproductive functions.41 Unlike pancreatic RNase A,
which has only RNase activity, Ears 1 through 8 are
secreted RNases that also possess potent bactericidal,
helminthotoxic, and antiviral properties when expressed
in cell lines. However, host defense functions for the
individual members of this protein family have not been
fully elucidated, yet appear to be specific for each mem-
ber. Moreover, RNase activity is necessary, but not suf-
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Figure 7. Electroporation-mediated gene deliv-
ery of Ear1 protects the respiratory epithelium of
lungs from infected mice exposed to hyperoxia
as neonates. Lungs of adult mice exposed to
room air (RA) or hyperoxia (O2) as neonates
were electroporated with empty vector (Con) or
plasmid-expressing Ear1 (Ear1). Mice were in-
fected with influenza A virus 48 hours later.
Lungs were harvested before infection (A) and
on postinfection day 5 (B). Lung homogenates
were immunoblotted for ABCA3, CCSP, E-cad-
herin, and -actin. Band intensities were quan-
tified and graphed relative to -actin. Neonatal
oxygen significantly reduced expression of
ABCA3, CCSP, and E-cadherin during infection.
(n  3 mice per group, *P  0.05) but not when
Ear1 was overexpressed (n  5 mice per group,
**P  0.05).BCA3 
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Ear1 specifically, recombinant rat Ear1 displays antimi-
crobial activity when expressed in cells, but little is known
in general about its function.42 Hence, our finding that
Ear1 also functions as an antiviral molecule in vivo pro-
vides a new role for this member of the RNase family. Our
finding that Ear1 is expressed by the respiratory epithe-
lium suggests it may function to limit viral or bacterial
growth during the early stages of an infection. Consistent
with this hypothesis, prophylactic delivery of Ear1 to na-
ive mice exposed to room air or hyperoxia at birth re-
duced viral titers and the associated inflammatory re-
sponse to influenza A virus infection. Hence, epithelial
expression of Ear1 adds to the growing list of innate
immune genes, such as SP-A and SP-D, that function as
first responders to respiratory pathogens.
Of the 14 known rodent members of the Ear protein
family, Ear1 and Ear2 were the only isoforms detected in
lungs of naive mice. Although this confirms an earlier
report,28 we extended those findings by showing airway
epithelium and a limited number of alveolar epithelial type
II cells express Ear mRNA. Ear protein staining was only
detected in type II cells, perhaps because they, like eo-
sinophils, contain large granules for storing secreted pro-
teins. Consistent with this hypothesis, Ear staining was
observed in some airway epithelial cells after viral infec-
tion (data not shown). Neonatal hyperoxia suppressed
Ear mRNA expression in the airway and depleted the
alveolus of type II cells expressing Ear. Prophylactic ad-
ministration of a plasmid expressing Ear1 reduced influ-
enza A virus infection and, more importantly, alleviated
the poorer outcomes from influenza virus infection
caused by neonatal hyperoxia. Interestingly, overexpres-
sion of Ear1 afforded less protection to infected mice
exposed to hyperoxia than to infected siblings exposed
to room air. This finding implies that Ear1 is unlikely the
sole target of neonatal oxygen. Nonetheless, long-term
dosing with anti-RSV antibodies, such as RSV-IGIV or
palivizumab, alleviates infection rates or pulmonary com-
plications seen in preterm infants with BPD.43,44 These
findings both suggest that antiviral modalities may be
efficacious in attenuating sensitivity to respiratory patho-
gens attributed to prematurity. As such, epithelial expres-
sion of Ear should be investigated as a potential bio-
marker and perhaps a therapeutic target for people at
risk for respiratory infections, such as those who were
born prematurely or had BPD. However, distinguishing
between epithelial and inflammatory sources of these
highly homologous members in humans will be challeng-
ing, particularly because levels of eosinophil cationic pro-
tein in tracheal aspirates, serum, and urine is already
used as a biomarker of airway inflammation and bron-
chial hyperresponsiveness in preterm infants and asth-
matic patients.45–48 Fortunately, this was not a concern
for the current study in which Ear expression could be
assessed in lung tissues harvested from naive mice that
did not show a difference in the number of immune cells
before infection.14
Another opportunity to learn more about Ear1 in the con-
text of viral infections is suggested by our observation that
administration of plasmids encoding Ear1 not only pro-tected against infection-associated morbidity and mortality
but also reduced leukocyte recruitment to the lung and
ameliorated infection-associated symptoms. Importantly,
reduced leukocyte accumulation in the lung was not due to
the attenuated recruitment of a single cell type. Macro-
phages, neutrophils, and lymphocytes were equally af-
fected by overexpression of Ear1. Reduced cellular infiltra-
tion to the infected lung could simply be due to early
reductions in viral load caused by elevated Ear levels. How-
ever, the protective effects of Ear likely extend beyond re-
ducing viral load because viral titers were only modestly
elevated in infected mice exposed to neonatal hyperoxia
and virus was effectively cleared by postinfection day 9.
There is precedence for an interface between Ear proteins
and signaling pathways that cue innate cell recruitment or
that bridge the innate and adaptive responses to infection.
For example, in addition to antiviral activity, Ear2 has been
reported to be chemotactic for mouse and human dendritic
cells.49 Dendritic cells are critical for the activation of naive,
virus-specific CD8 T cells, which differentiate cytotoxic T
lymphocytes that kill virus-infected cells in the lung. There is
some evidence that early dampening of viral replication
may reduce the magnitude of the CD8 T-cell response to
infection.50 However, other work suggests alterations in
early innate responses during an infection can result in
greater CD8 T-cell responses later51 and enhance infec-
tion-associated symptoms.52,53 Thus, the “stoichiometric”
and kinetic relationship among antigen load, early innate
responses, and the magnitude or nature of the adaptive
response to infection remains to be fully elucidated. Under-
standing how Ear modifies recruitment of leukocytes may
help clarify these complex interactions.
Altered recruitment of inflammatory cells and the as-
sociated cytokine-chemokine surge may contribute to the
enhanced epithelial injury and fibrosis observed in in-
fected mice exposed to hyperoxia as neonates. Severe
epithelial injury is often observed in fibrosis35,36 and was
observed in the current study as defined by a more
significant loss of ABCA3, CCSP, and E-cadherin expres-
sion. Although pulmonary fibrosis is not typically viewed as
a pathological outcome of viral infections, it is possible that
primary or secondary defects render a host more suscep-
tible to fibrosis after a second insult. Indeed, genetic disor-
ders controlling surfactant homeostasis have been linked to
interstitial lung fibrosis often diagnosed after a severe respi-
ratory viral infection (for review see Whitsett et al54). For
example, mutations in exon 4 of proSP-C disrupt normal
posttranslational processing, thereby activating endoplas-
mic reticulum stress and increasing sensitivity to RSV-in-
duced cell death.55 Similarly, mutations in ABCA3 have
been associated with childhood interstitial lung disease,
including desquamative interstitial pneumonia, nonspecific
interstitial pneumonitis, and occasionally usual interstitial
pneumonia.56–58 Some mutations in ABCA3 also elevate
endoplasmic reticulum stress and promote apoptosis.59
The loss of ABCA3 in infected mice exposed to hyperoxia
as neonates found in the current study provides strong
evidence that neonatal hyperoxia reprogrammed how
type II cells respond to influenza A virus infection. Under-
standing how this occurs and whether loss of ABCA3 by
type II cells contributes to disease progression or merely
450 O’Reilly et al
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clarify how neonatal hyperoxia sensitizes mice to influ-
enza A virus infection.
Our mouse model has several limitations that make it
difficult to directly compare our findings to children born
prematurely. For example, newborn term mice were ex-
posed to hyperoxia because it is not feasible to expose
preterm mice to oxygen in a manner that reflects oxygen
exposure in preterm humans. However, oxygen supple-
mentation in term mice is likely to model the effects seen in
preterm humans of 24 to 38 weeks’ gestation because both
have lungs in the saccular stage of development.60 Our
study also evaluated how neonatal oxygen reprogrammed
the host response to infection of young adult mice. It is not
known whether increased sensitivity to respiratory viral in-
fections, such as RSV, seen in children born prematurely is
retained when they become adults. However, less Ear pro-
tein is observed in lung homogenates of postnatal day 7
mice exposed to hyperoxia between birth and postnatal day
4, and agedmice (90 weeks old) exposed to hyperoxia as
neonates still show increased mortality compared with sib-
lings exposed to room air when infected with a sublethal
dose of influenza virus strain HKx31 (data not shown). This
finding suggests that children born prematurely may not
outgrow their sensitivity to influenza A virus as young or old
adults, but that remains to be determined. Our study also
began by using transgenic mice expressing EGFP in a
subpopulation of epithelial type II cells under control of the
human SP-C promoter. Whether these cells truly represent a
novel subpopulation of type II cells remains to be proven.
Perhaps the biggest limitation is not being able to harvest
respiratory epithelial cells from healthy children born pre-
maturely for determining expression of the human ortholog
of Ear proteins. However, reduced expression of Ear1 is
unlikely to be the only reason neonatal hyperoxia increases
sensitivity to influenza A virus in this mouse model because
overexpression of Ear1 was more effective at attenuating
the host response in infectedmice exposed to room air than
siblings exposed to hyperoxia. Identifying other innate im-
mune genes that contribute to oxygen-dependent sensitiv-
ity to infection may provide better molecular markers for
making comparisons between this mouse model and hu-
man disease.
In conclusion, the current study identifies a novel mech-
anism of innate host defense in respiratory epithelial cells
that is disrupted in young adult mice exposed to neonatal
hyperoxia. To our knowledge, this is the first report of Ear
genes being expressed by the respiratory epithelium, and it
adds to the growing list of epithelial-derived innate immune
genes expressed by type II cells. When expressed in young
adult mice, Ear1 served to reduce viral replication, inflam-
mation, and epithelial injury during infection with influenza
virus and alleviated some of the consequences of neonatal
hyperoxia, including poorer survival. Understanding how
neonatal hyperoxia reprograms epithelial expression of Ear
and other innate immune defenses may provide new op-
portunities for identifying and treating children born prema-
turely and who are at risk for a variety of respiratory infec-
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